Clinical Trial Update: A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports that REC-1245 is being studied in Phase 1/Phase 2 trials for unresectable, locally advanced, or metastatic cancers and relaps…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Lymphoma

Drugs mentioned

• REC-1245

Snippet

Sponsor: Recursion Pharmaceuticals Inc. | Conditions: Unresectable, Locally Advanced | Phase 1, Phase 2 | Status: RECRUITING